Confronting History and Health Inequities Together
October 20th 2023“There are things more important than our discomfort, and there are things that are more important than even our fear—inclusion is more important,” said Erica Marsh, MD, MSCI. “Our care of our patients and loved ones is more important, and our existence tomorrow has to be more important than our fears today.”
Read More
Higher Leptin Levels, Body Fat Linked to MDS in Study
October 20th 2023The authors discussed a polymorphism of the LEP gene associated not only with cancer, but also with chronic diseases including obesity and diabetes, offering them a reason to look into the relationship between LEP and myelodysplastic syndrome (MDS).
Read More
Three US senators asked the Social Security Administration to respond to a report saying it reduced or suspended benefits for those who received COVID-19 relief payments; mifepristone, a drug taken to help manage miscarriages, remains widely unavailable to patients experiencing pregnancy loss; pharmaceutical companies are beginning trials to get weight-loss shots approved for patients with obesity 6 years and older.
Read More
Intensive Therapy More Effective vs Less Intense Therapy in Frail Patients With MM
October 20th 2023A recent study suggests that more intensive triplet therapy is more effective than less intensive doublet therapy in frail patients with newly diagnosed multiple myeloma (MM), and that more intensive treatment may even improve frailty itself.
Read More
FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC
October 20th 2023The FDA has approved the CRCdx RAS Mutation Detection Kit as a companion diagnostic for panitumumab in the treatment of patients with metastatic colorectal cancer (mCRC), according to an announcement from EntroGen.
Read More
Burnout Decreases Quality of Life in Both Patients and Clinicians in Reproductive Health Fields
October 20th 2023Posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo addressed psychosocial symptoms and burdens faced by both embryologists and women of color with uterine fibroids.
Read More
Study: Heated Tobacco Products May Be Safer Than Combustible Cigarettes in COPD
October 20th 2023Researchers found that heated tobacco products can reduce risks of exacerbations and exposure to toxic chemicals compared with combustible cigarettes in patients with chronic obstructive pulmonary disease (COPD).
Read More
Cultural Humility, Pioneering Leadership Are Key to Address Health Disparities
October 19th 2023Valerie Montgomery Rice, MD, FACOG, a distinguished infertility specialist, highlights the pivotal role of cultural humility, diversity, acknowledgment of historical injustices, and collective action in addressing disparities and fostering equitable access to health care.
Read More
Million Hearts Payment Model Shows Prevention of CVD Outcomes Without Increasing Spending
October 19th 2023A 5-year randomized trial showed that the Million Hearts Model, which paid health care organizations to monitor and reduce cardiovascular disease (CVD) risk, was effective in reducing first-time heart attacks and strokes without associated increases in Medicare spending.
Read More
As More Gene Therapies Come to Market, Access and Affordability Remain Concerns
October 19th 2023Operational forecasting for patients who are eligible for gene therapies will be crucial for addressing the accessibility and affordability challenges with these agents, especially as more gene therapies are expected to enter the market in the next few years.
Read More
Dr Anita Allen Discusses the Current Regulatory Landscape on Abortions
October 19th 2023Anita Allen, PhD, professor of law and philosophy, University of Pennsylvania, discusses the impact of abortion regulations in different parts of the world on women's reproductive access and rights, as well as the repercussions of the Dobbs decision that overturned Roe v Wade.
Read More
Monica Bertagnolli, MD, fielded questions on hot-button issues during the long-delayed Senate hearing on her nomination to head the National Institutes of Health; Pfizer announces the list price for a 5-day course of its COVID-19 antiviral, nirmatrelvir/ritonavir (Paxlovid); a federal initiative is distributing funds to programs aiming to prevent drug overdoses in pregnant women.
Read More
Panelists Highlight Gaps in Research on Whether 340B Discount Program Is Working
October 19th 2023During a session at AMCP Nexus, panelists provided a historical overview on the 340B drug discount program, highlighting the intentions of the plan and the research gaps leading to misconceptions about the program and whether it’s working to lower costs for patients.
Read More
Panelists Discuss IRA Provisions Impacting Medicare in 2024 and Beyond
October 19th 2023Speakers at AMCP Nexus 2023 reviewed the major changes resulting from the Inflation Reduction Act (IRA) that impacted Medicare in 2023 and previewed the new provisions being implemented in the coming years.
Read More
Case Report of Patient Death Following High-Dose Gene Therapy for DMD
October 19th 2023In this case study, a patient who had Duchenne muscular dystrophy (DMD) and received high-dose transgene therapy to upregulate cortical dystrophin subsequently developed acute respiratory distress syndrome and died.
Read More